Position Purpose:
To promote CSL Behring’s products as defined by the company to HCPs in allocated clinics within the territory.
To deliver medical, financial and share goals of the business
To increase awareness towards the selected disease areas and the identification rates of the relevant diseases in defined geographical areas
Reporting Relationships:
Role this position reports to: National Sales Manager
Main Responsibilities and Accountabilities:
1-Responsible for achieving CSL Behring sales targets and effective management of defined regional accounts
2-Closely coordinates with National Sales Manager and Commercial Operation departments and serves as the primary interface between customers in the region and the company.
3-The position has responsibility for:
Identifying and visiting the hospitals & treating centers to find the patients with relevant diseases.
Raising awareness and interest for the related diseases in order to motivate patient screening in the visited centers.
Promoting the products during daily visits and at medical events
Developing and managing the relations with the Key Opinion Leaders in the territory.
Initiating and organizing medical training activities to increase knowledge levels on the diseases and products.
Providing support for the activities like clinical trials, patient surveys. etc.
Periodical review of progress against objectives and strategic plan.
Managing tender administration (bidding process, fulfilment) in close collaboration with the responsible functions (National Sales)
Evaluation of customer needs and facilitation of issues between the customer and other departments within CSL Behring
Creating, implementing and updating a CRM based visit plan to main customers as well as a detailed reporting of customer contacts, visits and meetings via Veeva
Position Qualifications and Experience Requirements:
Bachelor’s degree in life sciences, MD is a plus
Turkish – native, English – a plus
A min of 2-5 years RAM experience in innovative pharmaceutical or biotech pharmaceutical companies preferably in Biotech & Rare Disease area
additional Comments:
Travel within the region (60% of time)
This Position will work Izmir Region
About CSL Behring
CSL Behring is a global biotherapeutics leader driven by our promise to save lives. Focused on serving patients’ needs by using the latest technologies, we discover, develop and deliver innovative therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. We use three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and continually refine ways in which products can address unmet medical needs and help patients lead full lives.
CSL Behring operates one of the world’s largest plasma collection networks, CSL Plasma. Our parent company, CSL, headquartered in Melbourne, Australia, employs 32,000 people, and delivers its lifesaving therapies to people in more than 100 countries.
To learn more about CSL, CSL Behring, CSL Seqirus and CSL Vifor visit https://www.csl.com/ and CSL Plasma at https://www.cslplasma.com/.
Our Benefits
For more information on CSL benefits visit How CSL Supports Your Well-being | CSL.
You Belong at CSL
At CSL, Inclusion and Belonging is at the core of our mission and who we are. It fuels our innovation day in and day out. By celebrating our differences and creating a culture of curiosity and empathy, we are able to better understand and connect with our patients and donors, foster strong relationships with our stakeholders, and sustain a diverse workforce that will move our company and industry into the future.
To learn more about inclusion and belonging visit https://www.csl.com/careers/inclusion-and-belonging
Equal Opportunity Employer
CSL is an Equal Opportunity Employer. If you are an individual with a disability and need a reasonable accommodation for any part of the application process, please visit https://www.csl.com/accessibility-statement.
